Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana

Cognitive Brain Research

Volumn 17, Issue 2, 2003, Pages 454-461

  Kim, So Ra ^a   Kang, So Young ^a   Lee, Ki Yong ^a   Kim, Seung Hyun ^a   Markelonis, George J ^b   Oh, Tae H ^b   Kim, Young Choong ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition enhancing activity; Dementia; E p Methoxycinnamic acid; Scopolamine induced amnesia; Scrophularia buergeriana; Scrophulariaceae

Indexed keywords

4 METHOXYCINNAMIC ACID; BUERGERISIDE A; BUERGERISIDE C; ISOFERULIC ACID; PLANT EXTRACT; SCOPOLAMINE; SCROPHULARIA BUERGERIANA EXTRACT; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COGNITION; CONTROLLED STUDY; DEMENTIA; DRUG ACTIVITY; DRUG EFFICACY; DRUG SELECTIVITY; IN VIVO STUDY; LEARNING; LEARNING DISORDER; LONG TERM MEMORY; MALE; MAZE TEST; MEDICINAL PLANT; MEMORY; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SCROPHULARIA BUERGERIANA; SHORT TERM MEMORY;

SCROPHULARIA BUERGERIANA;

EID: 0037897480     PISSN: 09266410     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-6410(03)00161-7     Document Type: Article

References (29)

1. Beatty W.W., Butters N., Janowsky D.S. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behav. Neural. Biol. 45:1986;196-211.
2. Bejar C., Wang R.H., Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur. J. Pharm. 383:1999;231-240.
3. Bonner L.T., Peskind E.R. Pharmacologic treatments of dementia. Med. Clin. North Am. 86:2002;657-674.
4. Bushnell P.J. Modeling working and reference memory in rats: effects of scopolamine on delayed matching-to-position. Behav. Pharmacol. 1:1990;419-427.
5. Chiamulera C., Costa S., Reggiani A. Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning. Psychopharmacology. 102:1990;551-552.
6. Danysz W., Parsons C.G. Glycine, NMDA receptors-physiological significance and possible therapeutic applications. Pharmacol. Rev. 50:1998;597-664.
7. Doraiswamy P.M. Noncholinergic strategies for treating and preventing Alzheimer's disease. CNS Drugs. 16:2002;811-824.
8. Ellman G.L., Courtney K.D., Andre V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
9. Faiman C.P., Viu E., Skolnick P., Trullas R. Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure. J. Pharm. Exp. Ther. 270:1994;528-533.
10. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci. 14:1991;220-223.
11. Gibbs R.B., Burke A.M., Johnson D.A. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Horm. Behav. 34:1998;112-125.
12. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
13. Kim S.R., Hwang S.Y., Jang Y.P., Park M.J., Markelonis G.J., Oh T.H., Kim Y.C. Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities. Planta Med. 65:1999;218-221.
14. Kim S.R., Kim Y.C. Neuroprotective phenylpropanoid esters of rhamnose isolated from roots of Scrophularia buergeriana. Phytochemistry. 54:2000;503-509.
15. Kim S.R., Sung S.H., Jang Y.P., Markelonis G.J., Oh T.H., Kim Y.C. E-p-Methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate. Br. J. Pharmacol. 135:2002;1281-1291.
16. Kopelman M.D., Corn T.H. Cholinergic blockade as a model of cholinergic depletion. Brain. 111:1988;1079-1110.
17. Mantle D., Pickering A.T., Perry E.K. Medicinal plant extracts for the treatment of dementia: a review of their pharmacology, efficacy and tolerability. CNS Drugs. 13:2000;201-213.
18. Meldrum B.S., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
19. Morris R.G. Development of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11:1984;47-60.
20. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:1986;774-776.
21. Muir J.L., Page K.J., Sirinathsinghji D.J., Robbins T.W., Everitt B.J. Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention. Behav. Brain Res. 57:1995;123-131.
22. Nakazato E., Yamamoto T., Ohno M., Watanabe S. Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats. Life Sci. 67:2000;1139-1147.
23. Park C.H., Lee Y., Lee S., Choi S.H., Kim H.S., Jeong S., Kim S.S., Suh Y. Dehydroevodiamine·HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance. J. Neurochem. 74:2000;244-253.
24. Paule M.G., Bushnell P.J., Maurissen J.P., Wenger G.R., Buccafusco J.J., Chelonis J.J., Elliott R. Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicol. Teratol. 20:1998;493-502.
25. Schuster G.M., Schmidt W.J. D-Cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task. Eur. J. Pharmacol. 224:1992;97-98.
26. Shanghai Acad. Sci. and Shogaku Kan (Eds.), Dictionary of Chinese Herbal Medicine, Vol. 1-5, Shogukan Kan, Tokyo, 1985.
27. Trist D.G. Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications. Pharmaceut. Acta Helv. 74:2000;221-229.
28. Tsukada H. Delivery of radioligands for positron emission tomography (PET) in the central nervous system. Adv. Drug Deliv. Rev. 37:1999;175-188.
29. Wu C.R., Hsieh M.T., Huang S.C., Peng W.H., Chang Y.S., Chen C.F. Effects of Gastrodia elata and its active constituents on scopolamine-induced amnesia in rats. Planta Med. 62:1996;317-321.